Evidence map›Paper›PMID 41566251›Full record

ArticleBMC surgery2026

Multivariate integrated predictive model for 1-year mortality risk prognosis in patients undergoing esophageal cancer resection: establishment and validation.

Adilai Kurexi, Maimaiti Mijiti, Tingting Yuan, Yaozhong Zhang, Fanrong Wei, Rui Yan

Abstract readValidation Study
In one paragraph

Article in BMC surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Adilai KurexiTumor Hospital of Xinjiang Medical University (The Third Clinical Medical College of Xinjiang Medical University), Ürümqi, Xinjiang, China.
Maimaiti MijitiTumor Hospital of Xinjiang Medical University (The Third Clinical Medical College of Xinjiang Medical University), Ürümqi, Xinjiang, China.
Tingting YuanTumor Hospital of Xinjiang Medical University (The Third Clinical Medical College of Xinjiang Medical University), Ürümqi, Xinjiang, China.
Yaozhong ZhangTumor Hospital of Xinjiang Medical University (The Third Clinical Medical College of Xinjiang Medical University), Ürümqi, Xinjiang, China.
Fanrong WeiTumor Hospital of Xinjiang Medical University (The Third Clinical Medical College of Xinjiang Medical University), Ürümqi, Xinjiang, China.
Rui YanTumor Hospital of Xinjiang Medical University (The Third Clinical Medical College of Xinjiang Medical University), Ürümqi, Xinjiang, China. cgfb001@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo develop and validate a multidimensional prognostic model for predicting postoperative 1-year all-cause mortality in esophageal cancer patients by integrating clinical, hematological, tumor-related, and perioperative factors (including the Naples Prognostic Score, NPS), and to provide evidence for clinical risk stratification and individualized interventions.

methodsA retrospective analysis was conducted on 625 patients (≥ 18 years) who underwent esophageal cancer resection (January 2018–January 2023) at the Cancer Hospital Affiliated to Xinjiang Medical University. Ultimately, 521 eligible patients were enrolled and split into a training cohort (n = 364, 70%) and validation cohort (n = 157, 30%). LASSO regression was used for feature selection, and Cox univariate/multivariate analyses identified independent risk factors for 1-year mortality. Kaplan-Meier analysis compared survival differences by NPS and Clavien-Dindo classification.

resultsThe 1-year all-cause mortality rate was 20.0% (104/521). Independent predictors included anemia (assessed by red blood cell count), white blood cell count, NPS, Clavien-Dindo classification, and TNM stage (all P < 0.05). The model had an AUC of 0.82 (95% CI: 0.76–0.87) in the training cohort and 0.76 (95% CI: 0.66–0.86) in the validation cohort. Calibration curves and DCA confirmed good calibration and clinical utility. Kaplan-Meier analysis showed significant survival differences between NPS < 3 vs. ≥3 and Clavien-Dindo < 3 vs. ≥3 (both P < 0.0001).

conclusionThis multidimensional model effectively predicts postoperative 1-year mortality in esophageal cancer patients. With NPS as a core component, it provides a practical tool for perioperative risk stratification and individualized management to identify high-risk patients and reduce mortality.

Indexed as

Esophageal NeoplasmsEsophagectomyAgedFemaleHumansMaleMiddle AgedMultivariate AnalysisPrognosisRetrospective StudiesRisk AssessmentRisk Factors1-year mortalityNPSPostoperative Esophageal CancerPrognostic Model

Identifiers

PMID41566251
PMCPMC12906009

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.